↓ Skip to main content

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers

Overview of attention for article published in Journal of Hematology & Oncology, February 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
Published in
Journal of Hematology & Oncology, February 2020
DOI 10.1186/s13045-020-0846-y
Pubmed ID
Authors

F. Coussy, R. El Botty, M. Lavigne, C. Gu, L. Fuhrmann, A. Briaux, L. de Koning, A. Dahmani, E. Montaudon, L. Morisset, L. Huguet, L. Sourd, P. Painsec, S. Chateau-Joubert, T. Larcher, S. Vacher, S. Melaabi, A. Vincent Salomon, E. Marangoni, I. Bieche

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 22%
Student > Master 7 15%
Student > Bachelor 3 7%
Researcher 3 7%
Student > Postgraduate 2 4%
Other 4 9%
Unknown 17 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 26%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Medicine and Dentistry 4 9%
Agricultural and Biological Sciences 2 4%
Unspecified 1 2%
Other 2 4%
Unknown 21 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2020.
All research outputs
#13,596,788
of 23,195,584 outputs
Outputs from Journal of Hematology & Oncology
#643
of 1,203 outputs
Outputs of similar age
#177,661
of 361,698 outputs
Outputs of similar age from Journal of Hematology & Oncology
#8
of 20 outputs
Altmetric has tracked 23,195,584 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,203 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,698 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.